Emergent BioSolutions Congress Trades
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Dec 11, 2024
Emergent BioSolutions Congress trading summary
Members of Congress have disclosed 12 transactions in Emergent BioSolutions (EBS) stock, reported by 3 politicians. No EBS trades were reported with a transaction date in the past 12 months. The most active traders are Rep. Josh Gottheimer (6), Rep. Gilbert Ray Cisneros, Jr. (4), Rep. Steve Cohen (2).
The latest reported trade is a sale by Steve Cohen dated Dec 11, 2024 and disclosed on Jan 10, 2025. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading EBS
EBS trades by members of Congress
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell EBS. How Congress trading data works